Liliana M. HRUBYAK,

 PhD, Assistant to Professor, of the Department of Cardiology.

In 2001 she graduated from the Ternopil State Medical Academy. acad. I. Ya. Gorbachevsky.

From 2001 to 2002 she was the internship on the basis of the Ternopil Regional Clinical Hospital.

In 2002-2004– a clinical residency at the Department of faculty therapy at Ternopil State Medical University named after I. Ya. Gorbachevsky.

From 2004 to 2006 she was an assistant  to Professor of the Department of Pharmacology at Ternopil State Medical University named after I. Ya. Gorbachevsky.

From 2006 to 2016 she worked as the head of the advisory department of the Ternopil Regional Clinical Communal Psycho-Neurological Hospital, and from 2013 - a cardiologist.

Sinse 2016 she completed the training at the postgraduate study at the Department of Cardiology of the NMAPO named after P.L. Shupika.

Since 2017 she has been working as an assistant to Professor of the Department of Cardiology of the NMAPO named after P.L. Shupika.

In 2017 she defended a dissertation for the candidate of medical sciences in the specialty "Cardiology".

She is the author of 12 scientific papers published in the Ukrainian and foreign journals: "Pathogenetic factors and causes of stroke and clinical and functional characteristics of patients with ischemic stroke morbidity in patients with arterial hypertension," "Effect of angiotensin II receptor blockers and direct inhibitor of renin on morphofunctional state of the heart and central hemodynamics in patients with arterial hypertension after a transmitted ischemic stroke »,« Morpho-functional state of the heart and central hemodynamium in patients with arterial hypertension who have suffered an ischemic stroke "," Left ventricle myocardial function in hypertensive patients after acute ischemic stroke according to pulsed wave tissue Doppler imaging "," Risk factors modification in very high-risk patients with arterial hypertension in Ukraine and EU countries by EUROASPIRE IV. Results comparison "," Blood pressure control in very high-risk patients in Ukraine and Europe by EUROASPIRE IV. Results comparison ».